Lenva 10MG is a prescription medication used to treat advanced kidney cancer (renal cell carcinoma) and thyroid cancer (differentiated thyroid cancer).
Composition:
Lenva 10MG contains Lenvatinib (10mg), a tyrosine kinase inhibitor that targets the vascular endothelial growth factor (VEGF) receptor.
Mechanism of Action:
Lenva 10MG works by inhibiting the VEGF receptor, which is involved in the development of new blood vessels that feed tumors. By blocking the VEGF receptor, Lenva 10MG reduces the formation of new blood vessels, thereby reducing tumor growth and angiogenesis.
Uses:
Lenva 10MG is used to treat:
- Advanced kidney cancer (renal cell carcinoma) in patients who have not received prior treatment
- Advanced thyroid cancer (differentiated thyroid cancer) in patients who have progressed or are intolerant to other treatments
Dosage:
The recommended dosage of Lenva 10MG is:
- 10mg taken orally once daily, with or without food
- Continue treatment until disease progression or unacceptable toxicity
Side Effects:
Common side effects of Lenva 10MG include:
- Fatigue
- Hypertension
- Diarrhea
- Nausea and vomiting
- Abdominal pain
- Rash
- Hair loss
- Increased risk of bleeding
- Low platelet count
Recommendation:
Lenva 10MG is recommended for patients with advanced kidney cancer or thyroid cancer who have not received prior treatment. Patients should also be advised to monitor their blood pressure and blood counts regularly during treatment.
Important Note:
Patients should not take Lenva 10MG if they have a history of severe allergic reactions, uncontrolled hypertension, or bleeding disorders. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or liver problems, before taking Lenva 10MG.
Please note that Lenva 10MG is not available in all markets and may be approved for different indications and dosages in different regions.
Reviews
There are no reviews yet.